Navigation Links
Rigel to Present at BIO CEO & Investor Conference
Date:2/7/2013

SOUTH SAN FRANCISCO, Calif., Feb. 7, 2013 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower , the company's chairman and chief executive officer, is scheduled to present a company overview at the 15th Annual BIO CEO & Investor Conference in New York City on Monday, February 11th at 10:00 a.m. ET.

To access the live webcast of the presentation or the subsequent archived recording, log on to www.rigel.com. Please connect to Rigel's website several minutes prior to the start of the live webcast to ensure adequate time for any software download that may be necessary.

About Rigel (www.rigel.com)

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. Rigel's pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market its product candidates. Current product development programs include fostamatinib, an oral SYK inhibitor that is in Phase 3 clinical trials for rheumatoid arthritis with its partner AstraZeneca; R343, an inhaled SYK inhibitor for asthma and R333, a topical JAK/SYK inhibitor for discoid lupus – both of which have commenced Phase 2 clinical trials; and, R348, a topical JAK/SYK inhibitor in a Phase 1 clinical trial for the treatment of chronic dry eye.

Contact: Ryan Maynard 
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Rigel Announces First Quarter 2012 Financial Results
2. Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease
3. Rigel Announces Second Quarter 2012 Financial Results
4. Rigel Initiates Phase 2 Clinical Studies with R343 for Asthma and R333 for Discoid Lupus
5. Rigel to Present at UBS Global Life Sciences Conference
6. Rigel Announces Third Quarter 2012 Financial Results
7. Rigel to Present at Jefferies 2012 Global Healthcare Conference in London
8. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
9. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
10. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
11. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Feb. 27, 2015  Bionik Laboratories Corp. (OTC:DWTPD), a ... today that it acquired Bionik Laboratories, Inc., a ... the sale to qualified accredited investors of units consisting ... proceeds of approximately $6.2 million. Shares of the Company,s ... OTC Markets under the symbol "DWTPD" until FINRA,s approval ...
(Date:2/27/2015)... 27, 2015  Two mass spectrometry technologies ... as their effectiveness is established, according to ... Information says that while mass spectrometry (mass ... tool in proteomic biomarker discovery and validation, ... traditional techniques has struggled to elucidate molecular ...
(Date:2/26/2015)... RnRMarketResearch.com adds Corneal Ulcers ... to its store. This report p provides an ... The report "Corneal Ulcers - Pipeline Review, H2 2014" ... Corneal Ulcers. Corneal Ulcers are primarily result of ... infections & fungal infections. The symptoms of the ...
Breaking Medicine Technology:Bionik Laboratories Raises $6.2 Million 2Bionik Laboratories Raises $6.2 Million 3Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 2Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 4Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 5
... 22, 2012  Endo Pharmaceuticals Holdings (Nasdaq: ENDP ) ... a corporate overview at the Cowen & Co. 32nd Annual ... a.m. ET.  The conference will be held at the Boston ... webcast and audio archive of the presentation will be available ...
... 21, 2012  Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX ) ... at the Citi Global Healthcare Conference on February 27, 2012 ... York City.   The live and archived webcast ... Events" in the Idenix Investor Center at www.idenix.com ...
Cached Medicine Technology:
(Date:2/28/2015)... Heart diseases are on the rise in India. ... population and 5 percent of rural adult population suffer ... of them require specialized investigation and treatment to prevent ... (CVD). , A division of Indian Business News Agency ... “Indian Coronary Stent Market Forecast to 2019”. The new ...
(Date:2/28/2015)... Chicago, IL (PRWEB) February 28, 2015 ... growth, Chunk Fitness has added an additional exercise to ... as the oblique exercise is most commonly known as, ... equipment. , “Rope Pulls” are executed in a relatively ... varying fitness and strength levels. The full description of ...
(Date:2/28/2015)... 2015 March—also known as National ... remind ourselves and others that suspected head injuries, ... Specialists (ANS). , Concussions are a form of ... of TBIs. There are 1.6-3.8 million sports-related concussions ... but it is a brain injury. Many athletes ...
(Date:2/28/2015)... Fredericton, NB (PRWEB) February 28, 2015 ... call center software suite for Asterisk, are pleased to ... the highly successful 5.7 and 5.8 versions of Q-Suite, ... as well as a number of new features to ... be Q2 2015. , Q-Suite 5.9 will add features ...
(Date:2/28/2015)... MD (PRWEB) February 28, 2015 The ... present its annual awards at the International Symposium on ... will be held at the Hyatt Regency Bethesda in ... for their dedicated work and commitment to the mission ... the Year Award will be presented to Miriam Ratner. ...
Breaking Medicine News(10 mins):Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 3Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 2Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 3Health News:Indosoft Proudly Announces Q-Suite 5.9 Call Center Software for Asterisk 2Health News:Cancer Research Foundation Honors Award Recipients 2Health News:Cancer Research Foundation Honors Award Recipients 3Health News:Cancer Research Foundation Honors Award Recipients 4
... New study recommends pregnant women start an exercise program , ... recommend low to moderate levels of exercise to their pregnant patients, ... report published in the August 2009 issue of the ... According to this review article, exercise can strengthen and improve ...
... ... an accident, featuring music by Jack Johnson, Ben Harper, Jason Mraz, G. Love & others ... Los Angeles, CA (PRWEB) August 3, 2009 ... will be opening the Malibu Film Festival on Thursday, August 6th at the Malibu Cinemas. "Domestix ...
... , , , ... Preventive Medicine Examines Unintended Consequences ... while a necessary and positive trend for reducing exposure to secondhand ... of the American Journal of Preventive Medicine includes a ...
... PLAINSBORO, N.J., Aug. 3 Pharmacy & Healthcare ... Director of Pharmacy Times , a monthly journal that ... 112-year-old publication as well as its website, www.PharmacyTimes.com ... direct the custom supplements, including Pharmacy Times ...
... ATLANTA, Aug. 3 Blue Cross and Blue Shield ... for the administration of the H1N1 (swine flu) vaccine when ... administration will be covered for members whose benefit plans provide ... also continue coverage of seasonal flu vaccine administration for those ...
... microscopic tubes into tumors and heating them with a quick, ... to effectively kill kidney tumors in nearly 80 percent of ... cancer treatment for humans. The study appears in the ... of Sciences ). It is the result of a collaborative ...
Cached Medicine News:Health News:Exercise Is Healthy for Mom and Child During Pregnancy 2Health News:Exercise Is Healthy for Mom and Child During Pregnancy 3Health News:"Jesse's Story" to Open The 10th Annual Malibu Film Festival 2Health News:"Jesse's Story" to Open The 10th Annual Malibu Film Festival 3Health News:New Analysis: Women of Low Socio-Economic Status Face Unique Challenges Related to Smoking, Smoking Ban Policies 2Health News:New Analysis: Women of Low Socio-Economic Status Face Unique Challenges Related to Smoking, Smoking Ban Policies 3Health News:New Analysis: Women of Low Socio-Economic Status Face Unique Challenges Related to Smoking, Smoking Ban Policies 4Health News:New Analysis: Women of Low Socio-Economic Status Face Unique Challenges Related to Smoking, Smoking Ban Policies 5Health News:Pharmacy Times Names New Editorial Director 2Health News:BCBSGA Announces Decision to Cover H1N1 Vaccine Administration 2Health News:Researchers effectively treat tumors with use of nanotubes 2Health News:Researchers effectively treat tumors with use of nanotubes 3
For injecting anesthetics into the muscle cone. 25G x 1 1/2 in (.50 x 38mm)...
... most versatile diagnostic tool in the eye ... glaucoma, diabetic retinopathy, age-related macular degeneration and ... the only system in the market that ... the optic nerve areas in one session, ...
The modular osteosynthesis system for hand surgery offers a well-balanced range of self-tapping bone screws and bone plates for use in a wide variety of indications....
Stryker Leibinger offers a variety of different Titanium Implant Systems and special instrument sets, which enable our customers to treat a wide range of indication...
Medicine Products: